Jon Kiburz

Jon joined Immunocore in March 2022 from AstraZeneca, where he was Head of Oncology R&D Business Development Transactions. Jon has more than ten years of life sciences business development and strategy experience. Jon received a Master of Business Administration from Kellogg School of Management, a Juris Doctor from Northwestern University School of Law, and a Bachelor of Arts in biochemical sciences from Harvard University. Prior to his time at AstraZeneca, he was a strategy consultant at BCG and L.E.K. consulting and a life sciences transactional attorney at Ropes & Gray.